Philip Nickson

Insider Reports History

Entity
Individual
Location
Monte Rosa Therapeutics, Inc., 40 Guest Street, Boston, MA
Signature
/s/ Markus Warmuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip Nickson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. Chief Business & Legal Officer Common Stock 36K $339K $9.41 Jan 2, 2025 Direct
Monte Rosa Therapeutics, Inc. Chief Business & Legal Officer Stock Option (Right to Buy) 161K Jan 2, 2025 Direct

Insider Reports Filed by Philip Nickson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GLUE Monte Rosa Therapeutics, Inc. Jan 2, 2025 2 $0 4 Jan 6, 2025 Chief Business & Legal Officer
GLUE Monte Rosa Therapeutics, Inc. Jun 3, 2024 1 $0 4 Jun 5, 2024 Chief Business & Legal Officer
GLUE Monte Rosa Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 General Counsel
GLUE Monte Rosa Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 4, 2023 General Counsel
GLUE Monte Rosa Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 2, 2022 General Counsel
GLUE Monte Rosa Therapeutics, Inc. Mar 1, 2022 0 $0 3 Mar 2, 2022 General Counsel